Another Blood Pressure Medication Recall

Another blood pressure medication recall has happened after the company detected trace amounts of a cancer-causing chemical, N-nitrosodiethylamine (NDEA). The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets.

About NDEA

NDEA can exist naturally in certain foods and drinking water. However, it can also be in air pollution and industrial processes. Many industry materials also use it along with gasoline as a stabilizer. The International Agency for Research on Cancer warns that it can cause cancer in humans. Now, the FDA has pinpointed that NDEA in these heart medications was made by Zhejiang Huahai Pharmaceutical Company Co. Ltd. The FDA thus placed the Chinese company on an import alert at the end of September. This means all of its active pharmaceutical products and finished products will not be permitted to enter the United States. The FDA made that decision after an inspection of the facility.

Newest Blood Medication Recall

The FDA is advising patients on Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets to consult with their pharmacist or physician on alternative treatments. Last month, Torrent Pharmaceuticals Limited issued a voluntary recall of two lots of Losartan potassium tablets over similar concerns surrounding trace amounts of NDEA. And in November, Mylan Pharmaceuticals also issued a voluntary recall of some of its Amlodipine and Valsartan products for the same reason.

Multiple Carcinogens

Besides NDEA, several drug companies have voluntarily recalled their blood pressure and heart medication containing valsartan due to the impurity, N-nitrosodimethylamine or NDMA. NDMA can cause cancer. If you developed cancer from using valsartan, keep your medication. Testing your medication for NDMA can help prove if manufacturers are responsible for your cancer.

In July 2018, the FDA has asked three manufacturers of generic valsartan medication to voluntarily recall it from the U.S. market. Also, the agency asked pharmacists to return contaminated medications to the manufacturers. Furthermore, the agency is continuing to investigate the NDMA levels to asses cancer risks in those who already ingested the medication. the agency identified 13 other API manufacturers who supply more than 20 drug companies that make valsartan for the U.S. market. We made plans to determine if their products could also contain NDMA. Over 8,000 people received the highest dose of valsartan medications, and therefore the largest amount of the chemical.

Seek Justice

Many people after taking recalled heart medications are horrified to learn that their blood pressure meds could have caused their liver cancer. Thus, it is important to seek justice. These potentially cancer-causing drugs have been on the market for over 5 years. This is unacceptable. Therefore, you should hold these manufacturers accountable.

We want to help send a message that this is not acceptable. If a dangerous product harmed you, we will be your advocate. Additionally, we have the experience necessary to successfully litigate these cases.

Contact the Michael Brady Lynch Firm today for a free consultation to learn more about seeking justice. Compensation may be available for any medical expenses associated with this ordeal, as well as for your physical and emotional suffering. There is also no obligation.

Contact Us Today

Contact our lawyers directly through the email form below.





Type of Case

How did you find out about us?

×